Adaptimmune Therapeutics plc (NASDAQ:ADAP – Free Report) – Leerink Partnrs cut their Q2 2024 EPS estimates for shares of Adaptimmune Therapeutics in a research report issued on Wednesday, May 15th. Leerink Partnrs analyst J. Chang now forecasts that the biotechnology company will post earnings of ($0.17) per share for the quarter, down from their previous […]
Adaptimmune Therapeutics plc (NASDAQ:ADAP) Short Interest Update themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Adaptimmune Therapeutics plc (NASDAQ:ADAP – Get Free Report) gapped up before the market opened on Tuesday . The stock had previously closed at $1.01, but opened at $1.04. Adaptimmune Therapeutics shares last traded at $1.08, with a volume of 119,471 shares trading hands. Wall Street Analysts Forecast Growth Separately, StockNews.com assumed coverage on shares of […]
Adaptimmune Therapeutics (NASDAQ:ADAP) Shares Gap Up to $1.35 themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Adaptimmune Therapeutics (NASDAQ:ADAP) Shares Up 3.8% theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.